IR-Med Completes Insider-Backed Private Placement Financing
3 Best Data Center Stocks to Buy, According to Analysts
IR-Med Announces Insider-Backed Private Placement Amid CEO Exit
IR-Med Amends Executive Compensation Amid Financial Struggles
How Is Iron Mountain's Stock Performance Compared to Other Real Estate Stocks?
IR-Med Converts Debt Into Equity Shares
IR-Med Completes Private Placement Offering
IR-MED INC | 10-Q: Q2 2025 Earnings Report
IR-MED INC | 10-Q: Q1 2025 Earnings Report
IR-MED INC | 10-K: FY2024 Annual Report
IR-MED CEO Issues Letter to Shareholders: Expanding Our Platform and Presenting New Clinical Data From Israel and the U.S.
IR-MED INC | 10-Q: Q3 2024 Earnings Report
Methodist Healthcare Adopts IR-MED's PressureSafe Device for Usability Study: Decision Support Device Aims to Reduce Substantial Healthcare Burden of Pressure Injuries
Express News | Ir-Med Appoints Ran Ziskind, Tech Entrepreneur, Growth Manager, and Inventor as Chief Executive Officer
IR-MED Wins Prestigious Netty Award for Best Up-and-Coming Health Tech Company
IR-MED INC | 10-Q: Q2 2024 Earnings Report
IR-MED Receives $500,000 Grant From the Israel Innovation Authority to Develop Its Platform Technology for the Early Detection of Diabetic Foot Ulcers
IR-Med, Now on OTCQB, Files to Offer Units Consisting of Stock and Warrants and Seeks Nasdaq Capital Market Listing
Express News | Ir-Med Inc -Intend to Apply to List Common Stock and Warrants on Nasdaq Capital Market Under Symbols “Irme” and “Irmew”, Respectively
IR-MED's PressureSafe Reduced Pressure Injuries by 50% During a Usability Study With Clalit, Israel's Largest HMO